May Extends April’s Rebound from March Lows

OIS-Index
The OIS Index of ophthalmic stocks gained 7.9% in May, following a 12.2% gain in April, extending the rebound from the mid-March lows. Over the past three months, ophthalmic stocks have closely tracked the overall US stock market but have underperformed the biotech and medical device sectors.

The OIS Index exited May only 13% below its all-time high reached in February 2020, returning to levels seen as recently as six months ago. Biotech stocks have been particularly strong during this volatile period, with the NASDAQ Biotechnology Index posting its all-time high in May.

View Index here.

SHARE THIS ARTICLE WITH YOUR COLLEAGUES:

RECOMMENDED FOR YOU

OIS Index Q2

OIS Index Rallies Back from COVID-Driven Decline

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

Has Promising Cannabinoid-Based Drug Development Finally Come to Ophthalmology?

Has Promising Cannabinoid-Based Drug Development Finally Come to Ophthalmology?

About The Author

Michael Lachman

Michael Lachman is President of EyeQ Research, which provides market research, analytics, and strategic advisory to ophthalmic companies and investors. Previously, he was a healthcare investment research analyst with Hambrecht & Quist, ThinkEquity Partners, and SAC Capital, and worked in business development, marketing, and R&D for Johnson & Johnson and Baxter.

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Opthalmologic Innovation To Your Inbox.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

SUBSCRIBE TO OIS WEEKLY

Get our monthly newsletter about the latest in opthalmologic innovation.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

STAY CONNECTED

NEW VIDEOS

PODCASTS